Technology Mbiomics secures 30 million euros in Series A funding for gut microbiome cancer therapy Munich-based biotech firm mbiomics secured 30 million euros in a Series A funding round led by MIG Fonds and Bayern Kapital to push its gut microbiome cancer therapy into Phase 1B clinical trials. Emily Carter • Feb 20, 2025 • 2 min read